Argentina Prohibits Falsified Devices, Colombia Alerts on Philips Transducers, and Peru Executes Two Safety Actions

The week of June 22-29 was defined by post-market vigilance. Argentina prohibited two unregistered device categories with suspected falsification. Colombia's INVIMA issued a safety alert on reconditioned Philips ultrasound transducers. Peru's DIGEMID executed a market withdrawal and a field safety action within 48 hours of each other. Ecuador destroyed over a million irregular products and simultaneously signed an India cooperation MoU.

Argentina · Colombia · Peru · Ecuador

The week of June 22-29 was defined by post-market vigilance. Argentina prohibited two unregistered device categories with suspected falsification. Colombia's INVIMA issued a safety alert on reconditioned Philips ultrasound transducers. Peru's DIGEMID executed a market withdrawal and a field safety action within 48 hours of each other. Ecuador destroyed over a million irregular products and simultaneously signed an India cooperation MoU. The pattern across the region is unmistakable: LATAM regulators are enforcing the paperwork.

Argentina: ANMAT Prohibits Unregistered Surgical Clipper and Electrodes

ANMAT issued a June 26, 2026 alert prohibiting the commercialization, distribution and use of an unregistered surgical clipper and a set of electrodes with suspected falsification. A Mendoza-based company was summoned for violations of the registro sanitario regime. ANMAT alerts page.

Why It Matters: Chain-of-custody documentation is now part of the operational cost of doing business in Argentina. Distributors handling third-party device inventory should re-run supplier verification, particularly for consumables entering through Mendoza and other secondary port channels.

Colombia: INVIMA Alert 179-2026 on Reconditioned Philips Ultrasound Transducers

INVIMA published Alerta No. 179-2026 on June 26, 2026, covering reconditioned Philips ultrasound transducers under registration 2017DM-0016862 that were supplied in violation of local restrictions on reconditioned medical devices. INVIMA found no patient risk and permits temporary use while Philips coordinates free replacements. Affected distributors and importers are named in the alert. INVIMA alerta 179-2026.

Bottom Line: INVIMA's reconditioned-device rules are enforceable at the distributor level, not just the manufacturer. Sponsors selling refurbished imaging equipment into Colombia should confirm the reconditioning pathway is registered as a distinct commercial modality, not treated as an accessory to the original OEM registration.

Peru: DIGEMID Executes Two Post-Market Safety Actions in 48 Hours

DIGEMID issued two device safety actions in the June 24-26 window. Alert No. 67-2026 (June 26) mandates withdrawal of a specific lot of disposable closed suction catheters after a critical quality control failure. DIGEMID Alerta 67-2026. Separately, a June 24 Field Safety Corrective Action requires destruction of affected batches of the ICU Medical Tego Connector (registration DM15954E) due to silicone seal issues. DIGEMID FSCA notice.

What to Focus On: Manufacturers with active Peruvian registrations should confirm they have an in-country point-of-contact capable of executing lot-level recalls and coordinating destruction logistics on regulator-set timelines. DIGEMID is now routinely publishing FSCAs with specific batch destruction requirements — the compliance cost is executional, not administrative.

Ecuador: ARCSA Destroys Over 1M Irregular Products; Signs Cooperation MoU with India

ARCSA announced on June 25, 2026 the destruction of more than one million irregular products — including medical devices — through coordinated actions in Guayaquil and Quito, and simultaneously renewed its final-disposition partnership agreement. ARCSA press release. Days later, the Ecuadorian government signed a memorandum of understanding with India for cooperation on the regulation of pharmaceutical products, biologics and medical devices. El Telégrafo.

Why It Matters: ARCSA's enforcement posture and the India MoU signal the same underlying trend: Ecuador is opening additional formal reliance channels while simultaneously raising the cost of operating outside them. Indian device manufacturers now have a documented path toward market entry; conversely, distributors bringing in unregistered stock face rising interdiction risk.

Big Picture

  1. Post-market vigilance intensity crossed a threshold this week: five distinct enforcement or safety actions across four countries in seven days.
  2. Documentation obligations are now enforceable at every point in the supply chain — importer, distributor, reprocessor — not just at the manufacturer level.
  3. Manufacturer-led corrective actions with destruction requirements are the new norm in Peru; sponsors need in-country logistics partners capable of executing them.
  4. Ecuador's India MoU is the second bilateral regulator cooperation announcement in Latin America this quarter after the Mexico-Korea reference-agency arrangement — bilateral reliance is emerging as a stable mechanism for market entry from Asia.
  5. The week's absence of trade agreement, HTA and commercial registration items reinforces that vigilance and enforcement dominated the regulator calendar. Expect a rebound of commercial-registration activity in the July cycle.

Need Help Navigating LATAM Regulatory Pathways? bioaccess® provides market access services with U.S. regulatory anchoring and Latin American execution — from device registration to commercial launch. Visit bioaccessla.com/market-access

← All LATAM Regulatory Dispatch editions · Contact bioaccess®